about
Complex Minigene Library Vaccination for Discovery of Pre-Erythrocytic Plasmodium T Cell AntigensA Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune ResponseGM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primatesProspects for developing an effective particle-mediated DNA vaccine against influenza.HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates.Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses.Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.HIV vaccine trial exploits a dual and central role for innate immunity.Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates.Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines.Isolation, characterization, and functional analysis of ferret lymphatic endothelial cells.Laparoscopic Technique for Serial Collection of Para-Colonic, Left Colic, and Inferior Mesenteric Lymph Nodes in Macaques.Functional characterization of ferret CCL20 and CCR6 and identification of chemotactic inhibitors.Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens.'Omics investigations of HIV and SIV pathogenesis and innate immunity.Computational design of trimeric influenza-neutralizing proteins targeting the hemagglutinin receptor binding site.Kinetics of Myeloid-Derived Suppressor Cell Frequency and Function during Simian Immunodeficiency Virus Infection, Combination Antiretroviral Therapy, and Treatment Interruption.Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice.Effects of monotherapy with (R)-9-(2-phosphonylmethoxypropyl)adenine (PMPA) on the evolution of a primary Simian immunodeficiency virus (SIV) isolate.Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV.Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques.Multigenic DNA vaccine induces protective cross-reactive T cell responses against heterologous influenza virus in nonhuman primates.Correction: Laparoscopic Technique for Serial Collection of Para-Colonic, Left Colic, and Inferior Mesenteric Lymph Nodes in Macaques.Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device.Sustained AAV9-mediated expression of a non-self protein in the CNS of non-human primates after immunomodulation.Early cellular innate immune responses drive Zika viral persistence and tissue tropism in pigtail macaquesImmunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression fCorrection: Sustained AAV9-mediated expression of a non-self protein in the CNS of non-human primates after immunomodulationMucosal T helper 17 and T regulatory cell homeostasis correlates with acute SIV viremia and responsiveness to antiretroviral therapy in macaquesGene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNAExamination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunizationA qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccineVaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunitEngagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition
P50
Q28551311-16152C39-E3AC-456E-A355-CFA67E880985Q28553101-69E00333-744D-4885-A3C7-A172E8D0EC9FQ28751705-F8915812-BFED-4C19-8BF4-2A8494370AACQ30380300-B9B80F3F-392C-4C0B-BDF5-7D175CC46A8AQ30573155-031EE573-3B81-4409-BE49-421367BC73CBQ33686890-0EB9DBC1-A8B2-4DE4-9D57-77C46A4FB1C6Q33686890-9521F08D-038D-42EF-AE73-D524A97A3B04Q34226966-DCAA5E6A-15F3-4DBC-A0DE-DDC8B6D71E45Q34261579-EC735F30-489C-49E3-A8AB-0F27C7FC28A4Q34522384-FD8C6383-8DE7-4586-949A-67DFBFD6F52BQ34998726-9A917DA6-1A18-4F96-A37D-E4A87FE915BEQ35070965-B20BEB29-44B9-4C80-A7D7-6F2F1E4B32ECQ36054027-969A6F6A-EB4C-424E-A89F-9E4B90E5CFB4Q36677825-F5E4809B-1D7E-47A0-8B4A-C94C46E3AF41Q36702114-01D30A62-06AA-4B03-B4DA-9E4184F5B8E4Q38038089-56EACEE6-95E2-40AF-869D-50A02BF4B1EDQ40163658-CD0D1E14-355A-4B0F-93A9-7A6BF091F54DQ40409853-27F038D0-9E41-4A1F-A6C3-E4D0242A5071Q41346392-72E26D88-AAAB-4B15-ADEA-0FDC4B67B35CQ45413785-DDA0FC62-F8C8-4DCF-AB4A-D402FEF92C17Q45760257-391C9E6D-6D4F-4E11-B420-BA145C8E0F7BQ45761522-437E6325-D3D4-435C-8A8E-DD2B80C5A965Q47562002-164F8263-7FF3-40AB-9B3E-2751816CB87AQ48521540-C5DDF0C4-D4CB-4B62-9C07-B0BD2D0552F1Q51419221-6BE459A5-0B74-41D4-B566-062A9F7AE81BQ55194735-1ADBA603-609A-4878-A806-3BA1DF78A65AQ56338583-B2D8DC36-3884-48DB-9E7D-ED074BE05B5EQ57075677-1EE00C1D-074C-40C1-8243-52B73874C588Q58084942-B2F45D91-DB64-484A-9224-20CE7C6E784DQ58604129-7D3D65D0-7B32-43EE-B414-40B04000050CQ70944351-0CA95630-8062-4BC7-BCB2-EAD19BC0CACCQ72548371-0BEEF34F-3472-42F6-89D6-B979FC6A5AEBQ72625630-DEB5461E-85A6-47E3-B861-7C7F6C706C2AQ73537559-614E5A25-2103-4D68-BA23-A498B80FF1A3Q90263714-DE53230F-742A-427C-9406-F53249C0BF37
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Deborah H Fuller
@ast
Deborah H Fuller
@en
Deborah H Fuller
@es
Deborah H Fuller
@nl
type
label
Deborah H Fuller
@ast
Deborah H Fuller
@en
Deborah H Fuller
@es
Deborah H Fuller
@nl
prefLabel
Deborah H Fuller
@ast
Deborah H Fuller
@en
Deborah H Fuller
@es
Deborah H Fuller
@nl
P106
P31
P496
0000-0001-7315-2441